NDC 70511-162

Bortezomib

Bortezomib

Bortezomib is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Maia Pharmaceuticals, Inc.. The primary component is Bortezomib.

Product ID70511-162_2cc294fe-75e3-4ed9-8259-c6e5bc5e8286
NDC70511-162
Product TypeHuman Prescription Drug
Proprietary NameBortezomib
Generic NameBortezomib
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-08-10
Marketing CategoryNDA /
Application NumberNDA215331
Labeler NameMAIA Pharmaceuticals, Inc.
Substance NameBORTEZOMIB
Active Ingredient Strength3 mg/1
Pharm ClassesProteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70511-162-02

1 INJECTION in 1 VIAL, SINGLE-DOSE (70511-162-02)
Marketing Start Date2022-08-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Bortezomib" or generic name "Bortezomib"

NDCBrand NameGeneric Name
0143-9098bortezomibbortezomib
0409-1700BortezomibBortezomib
0409-1703BORTEZOMIBBORTEZOMIB
0409-1704BORTEZOMIBBORTEZOMIB
0781-3258bortezomibbortezomib for injection
10019-991BORTEZOMIBbortezomib
25021-244BORTEZOMIBBORTEZOMIB
43598-426BortezomibBortexomib
43598-865BortezomibBortexomib
50742-484BortezomibBortezomib
51817-586Bortezomibbortezomib
55150-337BORTEZOMIBBORTEZOMIB
60505-6050BORTEZOMIBbortezomib
63323-721BortezomibBortezomib
63323-821BortezomibBortezomib
67184-0530BortezomibBortezomib
68001-534BortezomibBortezomib
68001-540BortezomibBortezomib
68001-541BortezomibBortezomib
70511-161Bortezomibbortezomib
70511-162Bortezomibbortezomib
70710-1411BORTEZOMIBBORTEZOMIB
70771-1708BORTEZOMIBBORTEZOMIB
70860-225Bortezomibbortezomib
71288-118BortezomibBortezomib
72205-183BortezomibBortezomib
72266-243Bortezomibbortezomib
72266-244Bortezomibbortezomib
63020-049VELCADEbortezomib
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.